Vol 2005, No 56 (2005)

Table of Contents

Deal Trackers

Tysabri (natalizumab) Abstract pdf
Business Review Editor

Research & Development

Infinity’s Small Molecule Collaborations with Big Pharma Abstract pdf
Business Review Editor

Features

Ortho-McNeil's Re-Entry into the Diabetes Arena Abstract pdf
Business Review Editor
CAT and Abbott: A David and Goliath Story Abstract pdf
Business Review Editor
Deal Making in the Biopharmaceutical Sector Abstract pdf
Business Review Editor
Therapy Focus: Malaria Abstract pdf
Business Review Editor

Licensing

Centocor Partners Neurochem to Gain Access to Amyloidosis Drug Abstract pdf
Business Review Editor

General

Corixa Hands Over Bexxar® Rights to GSK Abstract
Business Review Editor
Micromet AG Abstract pdf
Business Review Editor

Mergers & Acquisitions

Johnson & Johnson’s US$25.4 B Acquisition of Guidant Abstract pdf
Business Review Editor
Solvay Pharmaceuticals Launches Friendly Takeover Bid for Neopharma Abstract pdf
Business Review Editor

Distribution & Marketing

GSK Transfers Levitra® Co-Promotion Rights Back to Bayer Abstract pdf
Business Review Editor

Business Commentaries

Preparing to Walk Away html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.